REGENXBIO Expands Pipeline Using NAV Vectors to Deliver Therapeutic Antibodies for the Treatment of Hereditary Angioedema and Neurodegenerative Diseases Read more
Uman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light Assay Read more
Sanofi signs strategic deal for exclusive US over-the-counter rights to Tamiflu in Flu Care Read more
FDA Approves Pfizer’s Biosimilar, RUXIENCE (rituximab-pvvr), for Certain Cancers and Autoimmune Conditions Read more
Merck and Eisai Receive Third Breakthrough Therapy Designation from FDA for KEYTRUDA (pembrolizumab) plus LENVIMA (lenvatinib) Combination Treatment Read more
Johnson & Johnson Establishes International Consortium to Advance Pioneering Science in the Fight to End Tuberculosis Read more
ContraVir Pharmaceuticals Announces Name Change to Hepion Pharmaceuticals, Inc.; Trading Symbol Change to “HEPA” Read more
Avalon GloboCare and GE Healthcare Announce Strategic Partnership to Accelerate Standardized Automation and Bio-production for Cellular Medicines Read more